Return of Cardiovascular Information: How Details Help or Hinder Change
Official title: The Return of Cardiovascular Information Trial (RECITE)
Run by University of Texas Southwestern Medical Center · NCT07613853 · Data updated 2026-11-12
This study tests whether presenting personal heart risk information in a detailed vs. a simpler format helps people in Dallas change their health habits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | April 22, 2026 |
| Main results expected | April 2028 |
| Study ends | August 2028 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07613853 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who completed the Dallas Heart Study Visit 4 and can use short links or QR codes to access information.
✕Probably not a fit
Individuals who did not attend DHS Visit 4 or cannot access the post-visit materials may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
RECITE is a multi-factorial randomized behavioral trial embedded within the Dallas Heart Study that tests how best to present personalized cardiovascular risk data. Participants are randomized to receive either a coarse or granular cover letter with their AHA PREVENT risk score and 10-year CVD risk, following their DHS visit, and are later surveyed about health behavior changes. The trial also examines whether additional action-planning support influences sustained behavior change. The two intervention components isolate the effect of risk information presentation and the potential benefit of structured planning tools. The study uses adaptive randomization to compare presentation formats and their impact on motivation and behavior at follow-up.
Why it matters
Potential benefit: If successful, the approach could improve how clinicians and researchers communicate risk and support lifestyle changes for better cardiovascular health.
How similar studies have gone: Past work in risk communication shows mixed results; this trial tests a specific, structured presentation against a granular format within a well-characterized cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Attendance of the Dallas Heart Study-4 clinical visit * Participant confirms ability and willingness to utilize short links/QR codes during clinical visit Exclusion Criteria: * Did not attend the Dallas Heart Study-4 clinical visit * Did not confirm ability and willingness to utilize short links/QR codes * Participants for whom a PREVENT-CVD score cannot be calculated (those who did not complete a laboratory collection, and/or height/weight measurements \[for BMI calculation\]), and/or BP assessment, and/or did not complete the medical history questionnaire)
Where it's running
-
UT Southwestern Medical Center
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Amil M Shah, MD, MPH — University of Texas Southwestern Medical Center
- Study coordinator: Deepa Raj, BA, MPH
- Email: deepa.raj@utsouthwestern.edu
- Phone: 214-648-9256
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breast Artery Calcification and Heart Health in Women
This study tests whether a breast artery calcification finding on a mammogram is linked to different cardiovascular markers in women 55–65 who do or do not have BAC.
-
Tirzepatide for methamphetamine use disorder (phase 2)
This phase 2 trial tests whether weekly tirzepatide injections can help adults with moderate to severe methamphetamine use disorder reduce use and improve outcomes compared with placebo.
-
Do beverage cues drive craving in adults with AUD
In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.
-
How foot braces might help people with ataxia walk better
This study tests whether wearing foot orthoses at home can improve gait and balance for adults with cerebellar ataxia.
-
Personalized Ultrafractionated Stereotactic Radiotherapy with Perioperative FLOT for GEJ and Esophageal Cancer
This trial tests adding a personalized, ultra-fractionated radiotherapy boost (PULSAR) to standard perioperative FLOT chemotherapy for patients with esophageal or gastroesophageal junction cancer to see if it can be used safely.
-
Hemophilia A: comparing long-acting FVIII replacement vs non-FVIII therapy in kids
This study tests whether children with moderate to severe Hemophilia A on long-acting FVIII or non-FVIII therapies form clots differently and develop small joint bleeds or early joint changes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.